Abstract: An object of the present invention is to provide a water-based magenta ink composition which has a hue and clarity suitable for ink-jet recording and gives prints excellent in fastnesses such as an ozone resistance and a light resistance.

Abstract: A recording medium is provided that exhibits both outstanding ink absorbency and outstanding light resistance of images, and an image forming method and a recorded matter using such recording medium are also provided. The recording medium in the present invention comprises a supporting body and an ink receiving layer deployed on that supporting body, and tho ink receiving layer contains a compound expressed by the general formula (I) below, and having a solubility in water of 0.01 to 5%. (where X is H, or an alkyl, aryl or other group; R1 to R4 is H or alkyl group; and Y is OH, or a carboxyl, alkyl, amino, alkenyl, alkoxy, aryl or other group. Y may also be a polymer. This compound may also be a polymer having X and Y as a main chain.

Abstract: An ink jet ink composition comprising water, a humectant and a mixture of a water-soluble, magenta anthrapyridone dye and Reactive Red 23, Reactive Red 24, Reactive Red 31, Reactive Red 120, Reactive Red 180, Reactive Red 241, Acid Red 35, Acid Red 52, Acid Red 249, Acid Red 289, Acid Red 388, Direct Red 227 or CAS No. 153204-88-7.

Abstract: Disclosed are compounds which inhibit &bgr;-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits &bgr;-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

Abstract: A color inkjet ink set for color printing having: (a) a yellow ink having a carrier and a yellow dye; (b) a magenta ink having a carrier and a mixture of a water-soluble, magenta anthrapyridone dye and Reactive Red 23, Reactive Red 24, Reactive Red 31, Reactive Red 120, Reactive Red 180, Reactive Red 241, Acid Red 35, Acid Red 52, Acid Red 249, Acid Red 289, Acid Red 388, Direct Red 227 or CAS No. 153204-88-7; and (c) a cyan ink having a carrier and a cyan dye.

Abstract: An ink-jet ink comprising water, a water-soluble organic solvent and a water-soluble dye, wherein the water-soluble dye is an anthrapyridone compound represented by Formula (1) or Formula (2): 1

Abstract: The present invention relates to anthrapyridone disulfonic acid represented by Formula (1) as shown below or the salt thereof, a water-based magenta ink composition containing the same, and a method for ink-jet recording by using the same. The compound of the present invention is excellent in water-solubility. The magenta ink composition containing the compound has a good storage stability. The product recorded by the ink-jet recording method appears with a vivid and reproducible hue, and has high light fastness and water fastness.

Abstract: The present invention is directed to a new class of serotonin 5HT2 antagonists and thier use in the treatment of a variety of diseases.

Abstract: The present invention relates to a novel anthrapyridone compound represented by Formula (1) as described below or the salt thereof which has hue and vividness suitable for ink-jet printing and give a print excellent in fastness to light and water, a water-based magenta ink composition containing any of the compounds or salt thereof, an ink-jet printing method using the ink composition and a new intermediate. wherein, R1 is hydrogen atom, an alkyl group etc; R2 is hydrogen atom, methyl etc; X and Y represent independently chlorine atom, hydroxy, etc.

Abstract: Naphthalene-1,4,5,8-tetracarboxylic bisimides of the general formula I 1

Abstract: A color ink jet ink set for color printing having a yellow ink of a carrier and a yellow azoaniline dye; a magenta ink of a carrier and a magenta anthrapyridone dye; and a cyan ink of a carrier and Direct Blue 307.

Abstract: This invention relates to compounds, pharmaceutical compositions, and methods of using the disclosed compounds for inhibiting PARP.

Abstract: A color inkjet ink set for color printing having: (a) a yellow ink having a carrier and a yellow dye; (b) a magenta ink having a carrier and a mixture of a water-soluble, magenta anthrapyridone dye and Reactive Red 23, Reactive Red 24, Reactive Red 31, Reactive Red 120, Reactive Red 180, Reactive Red 241, Acid Red 35, Acid Red 52, Acid Red 249, Acid Red 289, Acid Red 388, Direct Red 227 or CAS No. 153204-88-7; and (c) a cyan ink having a carrier and a cyan dye.

Abstract: An ink jet ink composition comprising water, a humectant and a mixture of a water-soluble, magenta anthrapyridone dye and Reactive Red 23, Reactive Red 24, Reactive Red 31, Reactive Red 120, Reactive Red 180, Reactive Red 241, Acid Red 35, Acid Red 52, Acid Red 249, Acid Red 289, Acid Red 388, Direct Red 227 or CAS No. 153204-88-7.

Abstract: The present invention relates to a water-based magenta ink composition which has satisfactory storage stability, has a hue and vividness suitable for ink-jet recording, and gives prints having high fastness to light and water, and a magenta dye suitable therefor. More particularly, the present invention relates to a water-based magenta ink composition characterized by containing a disulfonic acid derivative of a compound represented by Formula (2) or the salt thereof as the dye component, an ink-jet recording method using said composition, and magenta dye containing little inorganic salt and little mono-sulfonic acid compound and being suitable for the said composition.

Abstract: The present invention provides novel anthrapyridone compounds or salts thereof which have a magenta hue and vividness suitable for inkjet recording and give the recorded material having a high fastness in light fastness and water fastness. That is, the present invention relates to an anthrapyridone compound represented by Formula A-B or the salt thereof, wherein A is the dyestuff residue represented by Formula (1) (in the formula, R1 is hydrogen atom or an alkoxycarbonyl group and R2 is hydrogen atom or methyl group); and B is hydrogen atom or a substituent group on the dyestuff residue A, a water-based magenta ink composition which includes the said compound and an inkjet recording method which uses the said compound.

Abstract: Compounds having Formula I are useful for partially or fully antagonizing, repressing, agonizing, or modulating the glucocorticoid receptor in a mammal and treating immune, autoimmune and inflammatory diseases in a mammal. Also disclosed are pharmaceutical compositions comprising compounds of Formula I and methods of inhibiting immune or autoimmune diseases in a mammal.

Abstract: Poly(ADP-ribose) polymerase (“PARP”) inhibitors and methods for treating neurodegenerative diseases, neural tissue damage related to cerebral ischemia and reperfusion injury, and cardiovascular in an animal.

Abstract: The present invention relates to the development of a coloring matter which has a moderately bluish magenta color and an excellent lightfastness and can provide a wide range of color tones in the visible range when used together with yellow and cyan inks. A water-base ink composition or the like is prepared by using a sulfonic acid derivative of an anthrapyridone compound represented by general formula (I) as a magenta dye, wherein R.sub.1 ' represents alkoxycarbonyl, carbonyl or benzoyl; R.sub.2 represents hydrogen or alkyl; and R.sub.3 and R.sub.4 represent each independently hydrogen, halogeno, alkyl or alkoxy.

Abstract: Novel bis-1,2-dihydro-3H-dibenzisoquinoline-1,3-diones and their salts, processes for their preparation, pharmaceutical compositions containing them and methods of using them to treat malignancies, mainly human solid tumor carcinomas.

Abstract: This invention relates to a compound useful for the treatment of tumors having the formula: ##STR1##

Abstract: Disclosed herein are compounds pharmaceutical compositions containing same of the formula1. A compound of the Formula ##STR1## wherein X, X', X" and X'", A, B, D, R, and R' are as identified in the specification and their preparation. Pharmaceutical compositions containing same can be used in the treatment of cancer.

Abstract: Asymmetrically substituted bisnaphthalimides of the formula I ##STR1## in which A, B, D, R.sup.1, R.sup.2, m and have the meanings stated in the description, and the salts thereof with phsiologically tolerated acids, ale described. The novel compounds are suitable for controlling diseases.

Abstract: This invention relates to compounds useful in treating HT.sub.4 and/or HT.sub.3 mediated conditions of the formula ##STR1## or a pharmaceutically acceptable salt thereof; pharmaceutical compositions containing the compounds and a method for treating serotonin mediated condition with the compositionswhich act as 5-HT.sub.4 agonists or antagonists and/or 5-HT.sub.3 antagonists.

Abstract: A class of predominantly hydrophobic non-azo N-substituted 1,8-naphthalimide compounds, each bearing, at its 3-position, a nucleofuge and, at its 4-position, a heteroatomic electron-releasing group. The heteroatomic electron-releasing group is being characterized as having a heteroatom directly linked to the 4-position of the ring, and having at least one hydrogen directly attached to the heteroatom. Upon activation by an activating agent in an environment independent of the presence or absence of oxygen, these compounds generate activated species. The activated species initiate chemical changes in lipid bilayer membranes of viruses and other target cells. These changes can eradicate viruses and other target cells. The activated species can also cause structural changes in lipid and any associated proteins and polypeptides at a level beneath the surface of the membrane, leading to polymerization and crosslinking.

Abstract: An anthrapyridone compound of the following formula (I) and which is useful for coloring resins: ##STR1## wherein X.sup.1 is hydrogen, --NHCOR.sup.1, --CONR.sup.2 R.sup.3, --COR.sup.4, --SO.sub.2 R.sup.5 or --SO.sub.2 NR.sup.6 R.sup.7, in which R.sup.1 and R.sup.4 are each C.sub.1-4 alkyl, R.sup.2 and R.sup.3 are each hydrogen or C.sub.1-4 alkyl, R.sup.5 is C.sub.1-4 alkyl or hydroxyethyl, R.sup.6 and R.sup.7 are each hydrogen or C.sub.1-4 alkyl, X.sup.2 is hydrogen or imidomethyl of the formula (II): ##STR2## wherein n is a number of 1 to 2, X.sup.4 is hydrogen or carboxylic acid C.sub.1-4 alkyl-ester, X.sup.3 is hydrogen, halogen, hydroxyl, C.sub.1-4 alkyl or C.sub.1-4 alkoxyl, with the proviso that X.sup.1 is --NHCOR.sup.1, --CONR.sup.2 R.sup.3, --COR.sup.4, --SO.sub.2 R.sup.5 or --SO.sub.2 NR.sup.6 R.sup.7 when X.sup.2 is hydrogen, X.sup.2 is the imidomethyl of the formula (II) when X.sup.1 is the hydrogen, is provided, which is prepared by allowing an .alpha.

Abstract: This invention relates to unsymmetrical bis-imide compounds, and pharmaceutically acceptable salts thereof, of the formula (i): ##STR1## including (R,R)-1-[2-(acenaphthene-5,6-dicarboximido) propylamino]-2-[2-(3-nitronaphthalene-1,8-dicarboximido) propylamino]ethane, processes for the preparation of such compounds, pharmaceutical compositions containing such compounds, and methods of using such compounds to treat cancer, particularly solid tumor carcinomas, in mammals.

Abstract: Provided is an improved process for the synthesis of 1-cyano-3H-dibenz[f,ij] isoquinoline-2,7-dione compounds, and process exhibiting improvements in quality of products, safety, fewer environmental concerns and economics when compared to presently known processes. The compounds are useful as colorants for polyesters, and selected compounds and when combined with small quantities of certain red colorants are particularly efficacious as blue toners for polyesters.

Abstract: Provided is an improved process for the synthesis of 1-cyano-3H-dibenz[f,ij] isoquinoline-2,7-dione compounds, and process exhibiting improvements in quality of products, safety, fewer environmental concerns and economics when compared to presently known processes. The compounds are useful as colorants for polyesters, and selected compounds and when combined with small quantities of certain red colorants are particularly efficacious as blue toners for polyesters.

Abstract: An anthrapyridone compound of the following formula (I), which is useful for coloring synthetic resins: ##STR1## wherein Q is --NH.sub.2, --NHCH.sub.3 or --NHCOZ where Z is phenyl or alkyl which may be substituted; X.sub.1, X.sub.2 and X.sub.3 are each hydrogen, halogen, alkyl, alkoxy, hydroxy, --NHCOR.sup.1, --CONR.sup.2 R.sup.3 m --COR.sup.4, --COOR.sup.5, --SO.sub.2 R.sup.6 or --SO.sub.2 NR.sup.7 R.sup.8 where R.sup.1 and R.sup.4 are each C.sub.1-4 alkyl, R.sup.2 and R.sup.3 are each hydrogen or C.sub.1-4 alkyl, R.sup.5 and R.sup.6 are each alkyl or hydroxyalkyl and R.sup.7 and R.sup.8 are each hydrogen or C.sub.1-4 alkyl, with proviso that when Q is --NHCH.sub.3, X.sub.1, X.sub.2 and X.sub.3 are each hydrogen, halogen, alkoxy, hydroxy, --NHCOR.sup.1, --CONR.sup.2 R.sup.3, --COR.sup.4, --COOR.sup.5, --SO.sub.2 R.sup.6 or --SO.sub.2 NR.sup.7 R.sup.8.Process for producing the anthrapyridone compound is also provided.

Abstract: There are provided novel bis-napthalimide compounds useful as antitumor agents, pharmaceutical compositions containing them and processes for preparing intermediates to such compounds.

Abstract: An anthrapyridone compound of the following formula (I) and which is useful for coloring resins: ##STR1## wherein X.sup.1 is hydrogen, --NHCOR.sup.1, --CONR.sup.2 R.sup.3, --COR.sup.4, --SO.sub.2 R.sup.5 or --SO.sub.2 NR.sup.6 R.sup.7, in which R.sup.1 and R.sup.4 are each C.sub.1-4 alkyl, R.sup.2 and R.sup.3 are each hydrogen or C.sub.1-4 alkyl, R.sup.5 is C.sub.1-4 alkyl or hydroxyethyl, R.sup.6 and R.sup.7 are each hydrogen or C.sub.1-4 alkyl, X.sup.2 is hydrogen or imidomethyl of the formula (II): ##STR2## wherein n is a number of 1 to 2, X.sup.4 is hydrogen or carboxylic acid C.sub.1-4 alkyl-ester, X.sup.3 is hydrogen, halogen, hydroxyl, C.sub.1-4 alkyl or C.sub.1-4 alkoxyl, with the proviso that X.sup.1 is --NHCOR.sup.1, --CONR.sup.2 R.sup.3, --COR.sup.4, --SO.sub.2 R.sup.5 or --SO.sub.2 NR.sup.6 R.sup.7 when X.sup.2 is hydrogen, X.sup.2 is the imidomethyl of the formula (II) when X.sup.1 is the hydrogen, is provided, which is prepared by allowing the .alpha.

Abstract: Polycyclic 1,3-dione imides N-alkylated with variously N-substituted alkyl- or cycloalkyl amines afford histamine H.sub.1 -receptor antagonists of the formula ##STR1## wherein R is polycyclic alkyl moiety;R.sup.1 is hydrogen or alkyl;R.sup.4 is an aromatic amine or a cycloalkyl amine containing N-substitution;R.sup.7 and R.sup.8 are hydrogen, alkyl or form a spiro cycloalkyl group.

Abstract: Novel substituted isoquinoline compounds of the formula ##STR1## wherein R is lower alkyl,R.sub.1 is lower alkylene, 1-3 lower alkyleneoxy groups or lower alkylenethio, andX is one or more substitutents selected from the group consisting of hydroxyl, carbalkoxy, carboxy and acyloxy.These novel substituted isoquinolines can be used as dyes, toners or color bodies, and in particular as toners for polyesters.

Abstract: This invention relates to novel fiber forming polyester compositions that exhibit improved whiteness by incorporating derivatives of dibenzoisoquinolinediones of the formula ##STR1## wherein R is hydrogen, cycloalkyl, allyl, alkyl, aralkyl, alkoxyalkyl or cycloalkylalkylene;R.sub.1 is hydrogen, halogen, alkyl, alkoxy, aryloxy, alkylthio or arylthio;R.sub.2 is hydrogen, halogen, alkyl, aryl, alkoxy, aryloxy, alkylthio, arylthio, carbalkoxy, carbaryloxy, carbaralkyloxy, carboxy, sulfamoyl, alkylsulfamoyl, dialkylsulfamoyl, alkylarylsulfamoyl, cycloalkylsulfamoyl, arylsulfamoyl, carbamoyl, alkylcarbamoyl, dialkylcarbamoyl, alkylarylcarbamoyl, cycloalkylcarbamoyl, arylcarbamoyl, 2-pyrrolidono, acylamido or N-alkylacylamido;R.sub.

Abstract: Anthrapyridones are prepared in high yields from 1-aminoanthraquinones or 1-alkylaminoanthraquinones and phenylacetyl halides when tertiary amides are employed as reaction media. The phenylacetyl halides can be generated in situ from phenylacetic acid and thionyl halide or phosgene.

Abstract: A process for preparing cyclic amides from an optionally substituted acetic acid and an aromatic aminocarbonyl compound is disclosed. The process employs a promoter comprising tetravalent titanium or silicon and a pyridine compound to effect formation of the cyclic amides.

Abstract: Acetylation of residual primary and secondary alkyl amine groups in polymeric colorants, when said colorants are in the form of a crude preparation reaction mixture, is disclosed. The acetylation improves the colorants' water solubility.

Abstract: A process for preparing a family of orange polymeric colorants having a plurality of units of the chromophore ##STR1## is disclosed. R.sub.1 and R.sub.2 are hydrogens, lower alkyls or alkoxies, nitros, halos or sulfonates, R.sub.3 is benzyl, benzyl sulfonate, lower alkyl or alkyl sulfonate, R.sub.4 is hydrogen or lower alkyl. With the disclosed process, the chromophore units, less the R.sub.3 substituent, are bonded to an organic polymer backbone. The R.sub.3 substituent is added thereafter in a separate second step.

Abstract: The ultrafiltration purification of aqueous solutions of polymeric colorants, wherein low molecular weight impurities are removed in an ultrafiltrate leaving a purified polymeric colorant-bearing retentate, is carried out with improved efficiency when during at least 2 diavolumes of ultrafiltration, the pH of the retentate is maintained above about pH 9.0.

Abstract: Polyfluorohydroxyisopropyl bicyclic and tricyclic carbostyrils, such as 1,2-dihydro-8-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]-6-methy l-4H-pyrrolo-[3,2,1-ij]quinolin-7-one, useful as antihypertensive agents.

Abstract: Polymeric orange colors are disclosed having a noncrosslinked organic polymer backbone to which is covalently bonded a plurality of chromophores having a particular anthrapyridine structure. The colors are represented structurally as ##STR1## wherein R.sub.1 and R.sub.2 are independently selected from among hydrogen, halos, lower alkyls, lower alkoxies, nitros, and sulfonates; R.sub.3 is selected from hydrogen, alkyls and alkylsulfonates; R.sub.5 is a lower alkyl or lower alkyl sulfonate and R.sub.4 is a noncrosslinked organic polymer linking a plurality (k) of said anthrapyridines into a polymeric colorant. The polymeric colorants are especially useful as nonabsorbable orange colorants for edibles.

Abstract: Orange colors having the anthrapyridine structure ##STR1## are disclosed wherein R.sub.1 and R.sub.2 are independently selected from among hydrogen, halos, lower alkyls, lower alkoxies, nitros, and sulfonates, R.sub.3 and R.sub.4 are independently selected from hydrogens, alkyls and alkylsulfonates of 1 through 3 carbon atoms and R.sub.5 is a lower alkyl or lower alkyl sulfonate.

Abstract: Red colors having the anthraquinone structure ##STR1## are disclosed wherein R.sub.1 and R.sub.2 are independently selected from among hydrogen, halos, lower alkyls, lower alkoxies, nitros, and sulfonates, and R.sub.3 and R.sub.4 are independently selected from hydrogens, alkyls and alkylsulfonates. Precursors are disclosed as well. In a preferred embodiment R.sub.4 is an alkyl-containing polymer linking a plurality of anthraquinones into a polymeric colorant especially useful as a nonabsorbable colorant for edibles.

Abstract: Acetylation of residual primary and secondary alkyl amine groups present in the structure of polymeric colorants and the acetylated colorant products are disclosed. The acetylation is a post production step. The acetylation improves the colorants' water solubility.